ticlopidine has been researched along with Brain Emboli in 38 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Randomised trials have shown the efficacy of antiplatelet therapy with cilostazol to prevent secondary ischaemic stroke." | 7.81 | Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy. ( Hayashi, K; Horie, N; Izumo, T; Kaminogo, M; Nagata, I; Tsujino, A, 2015) |
| "The CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial proved the effectiveness of the combination of clopidogrel and aspirin compared with aspirin alone in reducing presence and number of microembolic signals (MES) in patients with recently symptomatic carotid stenosis." | 7.73 | The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. ( Dittrich, R; Droste, DW; Kaps, M; Larrue, V; Lees, K; Markus, HS; Nabavi, DG; Ringelstein, EB; Ritter, MA; Siebler, M, 2006) |
| " In a previous study, we found that the number of MESs is associated with stroke recurrence and that clopidogrel plus aspirin more effectively reduce the number of MESs than does aspirin alone." | 5.22 | The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial. ( Chen, C; Deng, QQ; Fu, JH; Huang, YN; Markus, H; Ratanakorn, D; Tang, J; Wong, KS; Zhao, H, 2016) |
| "We examined the efficacy and safety of dual antiplatelets in patients with transient ischemic attack or minor stroke, defined as National Institute of Health Stroke Scale scores 0-3, in a subgroup analysis of Clopidogrel plus aspirin versus Aspirin alone for Reducing embolization in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR) study." | 5.19 | Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study. ( Chen, C; Fu, J; Han, Z; Huang, Y; Lau, AY; Leung, TW; Markus, HS; Ratanakorn, D; Suwanwela, NC; Tan, KS; Wong, KS; Zhao, Y, 2014) |
| " Three preventive strategies were identified: (i) intra-operative transcranial Doppler (TCD) ultrasound and completion angioscopy which virtually abolished intra-operative stroke, primarily through the removal of residual luminal thrombus prior to restoration of flow; (ii) dual antiplatelet therapy with a single 75-mg dose of clopidogrel the night before surgery in addition to regular 75 mg aspirin which virtually abolished post-operative thromboembolic stroke and may also have contributed towards a decline in stroke/death following major cardiac events; and (iii) the provision of written guidance for managing post-CEA hypertension which was associated with virtual abolition of intracranial haemorrhage and stroke as a result of hyperperfusion syndrome." | 4.89 | Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy. ( Bell, PR; Bown, MJ; Dennis, MJ; London, NJ; McCarthy, MJ; Nasim, A; Naylor, AR; Sayers, RD, 2013) |
| "Randomised trials have shown the efficacy of antiplatelet therapy with cilostazol to prevent secondary ischaemic stroke." | 3.81 | Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy. ( Hayashi, K; Horie, N; Izumo, T; Kaminogo, M; Nagata, I; Tsujino, A, 2015) |
| "The CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial proved the effectiveness of the combination of clopidogrel and aspirin compared with aspirin alone in reducing presence and number of microembolic signals (MES) in patients with recently symptomatic carotid stenosis." | 3.73 | The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial. ( Dittrich, R; Droste, DW; Kaps, M; Larrue, V; Lees, K; Markus, HS; Nabavi, DG; Ringelstein, EB; Ritter, MA; Siebler, M, 2006) |
| "Within a cross-sectional study, nested in a cohort we identified 931 patients with a recent ischemic stroke or TIA who were discharged with OAC or with one of the antiplatelet medications aspirin, clopidogrel, or the combination of aspirin and extended-release dipyridamole." | 3.71 | Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry. ( Lalouschek, W; Lang, W; Müllner, M, 2001) |
| "In one patient a transient ischemic attack occurred." | 2.78 | High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial. ( Ackerstaff, RG; Breet, NJ; De Vries, JP; Deneer, VH; Elsenberg, EH; Hackeng, CM; Kelder, JC; Schonewille, WJ; Suttorp, MJ; Ten Berg, JM; Tromp, SC; Van Der Heyden, J; Van Neerven, D; Van Werkum, J; Vos, JA; Wolters, F, 2013) |
| "Dual treatment with aspirin (5 mg kg(-1) ) and clopidogel (0." | 1.43 | A rabbit model of cerebral microembolic signals for translational research: preclinical validation for aspirin and clopidogrel. ( Chu, L; Desai, K; Gutstein, DE; Kurowski, S; Seiffert, D; Wang, X; Wu, W; Zhou, X, 2016) |
| " A loading dosage of aspirin (500 mg) and/or clopidogrel (300 mg) was given 24 hours before the procedure to patients naïve to antiplatelet agents, whereas the usual dosage (aspirin 100 mg and clopidogrel 75 mg) was continued for patients who had previously been taking these agents for more than a week." | 1.40 | Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting. ( Jung, JM; Kang, DW; Kim, BJ; Kim, JS; Kwon, JY; Kwon, SU; Lee, DH, 2014) |
| "Intracranial arterial stenosis (IAS) is thought to be responsible for 8% of all ischemic stroke subtypes." | 1.37 | The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis. ( Derksen, C; Khan, K; Saqqur, M; Sebastian, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (52.63) | 29.6817 |
| 2010's | 18 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeeb, N | 1 |
| Griessenauer, CJ | 1 |
| Foreman, PM | 1 |
| Moore, JM | 1 |
| Shallwani, H | 1 |
| Motiei-Langroudi, R | 1 |
| Alturki, A | 1 |
| Siddiqui, AH | 1 |
| Levy, EI | 1 |
| Harrigan, MR | 1 |
| Ogilvy, CS | 1 |
| Thomas, AJ | 1 |
| Kinsella, JA | 1 |
| Oliver Tobin, W | 1 |
| Tierney, S | 1 |
| Feeley, TM | 1 |
| Egan, B | 1 |
| Coughlan, T | 1 |
| Ronan Collins, D | 1 |
| O'Neill, D | 1 |
| Harbison, JA | 1 |
| Doherty, CP | 1 |
| Madhavan, P | 1 |
| Moore, DJ | 1 |
| O'Neill, SM | 1 |
| Colgan, MP | 1 |
| Saqqur, M | 2 |
| Murphy, RP | 1 |
| Moran, N | 1 |
| Hamilton, G | 1 |
| McCabe, DJH | 1 |
| Lau, AY | 1 |
| Zhao, Y | 1 |
| Chen, C | 2 |
| Leung, TW | 1 |
| Fu, J | 1 |
| Huang, Y | 1 |
| Suwanwela, NC | 1 |
| Han, Z | 1 |
| Tan, KS | 1 |
| Ratanakorn, D | 2 |
| Markus, HS | 2 |
| Wong, KS | 2 |
| Naylor, AR | 2 |
| Sayers, RD | 1 |
| McCarthy, MJ | 1 |
| Bown, MJ | 1 |
| Nasim, A | 1 |
| Dennis, MJ | 1 |
| London, NJ | 2 |
| Bell, PR | 2 |
| Delgado Almandoz, JE | 1 |
| Kadkhodayan, Y | 1 |
| Crandall, BM | 1 |
| Scholz, JM | 1 |
| Fease, JL | 1 |
| Tubman, DE | 1 |
| Kim, BJ | 2 |
| Kwon, JY | 1 |
| Jung, JM | 1 |
| Lee, DH | 3 |
| Kang, DW | 2 |
| Kim, JS | 2 |
| Kwon, SU | 3 |
| Horie, N | 1 |
| Kaminogo, M | 1 |
| Izumo, T | 1 |
| Hayashi, K | 1 |
| Tsujino, A | 1 |
| Nagata, I | 1 |
| Flechtenmacher, N | 1 |
| Kämmerer, F | 1 |
| Dittmer, R | 1 |
| Budde, U | 1 |
| Michels, P | 1 |
| Röther, J | 1 |
| Eckert, B | 1 |
| Zhou, X | 1 |
| Kurowski, S | 1 |
| Wu, W | 1 |
| Desai, K | 1 |
| Chu, L | 1 |
| Gutstein, DE | 1 |
| Seiffert, D | 1 |
| Wang, X | 1 |
| Deng, QQ | 1 |
| Tang, J | 1 |
| Markus, H | 1 |
| Huang, YN | 1 |
| Zhao, H | 1 |
| Fu, JH | 1 |
| Einecke, D | 1 |
| Connolly, S | 1 |
| Healey, JS | 1 |
| Apostolakis, S | 1 |
| Shantsila, E | 1 |
| Lip, GY | 1 |
| Lane, DA | 1 |
| Sebastian, J | 1 |
| Derksen, C | 1 |
| Khan, K | 1 |
| Wandeler-Meyer, K | 1 |
| Bremerich, J | 1 |
| Christ, M | 1 |
| Rechner, AR | 1 |
| Vidal-Jordana, A | 1 |
| Barroeta-Espar, I | 1 |
| Sáinz Pelayo, MP | 1 |
| Mateo, J | 1 |
| Delgado-Mederos, R | 1 |
| Martí-Fàbregas, J | 1 |
| Lee, SW | 1 |
| Park, SW | 1 |
| Weber, R | 1 |
| Weimar, C | 1 |
| Wanke, I | 1 |
| Möller-Hartmann, C | 1 |
| Gizewski, ER | 1 |
| Blatchford, J | 1 |
| Hermansson, K | 1 |
| Demchuk, AM | 1 |
| Forsting, M | 1 |
| Sacco, RL | 1 |
| Saver, JL | 1 |
| Warach, S | 1 |
| Diener, HC | 1 |
| Diehl, A | 1 |
| Tsivgoulis, G | 1 |
| Kerasnoudis, A | 1 |
| Krogias, C | 1 |
| Vadikolias, K | 1 |
| Meves, SH | 1 |
| Heliopoulos, I | 1 |
| Georgakarakos, E | 1 |
| Piperidou, C | 1 |
| Alexandrov, AV | 1 |
| Van Der Heyden, J | 1 |
| Van Werkum, J | 1 |
| Hackeng, CM | 1 |
| Kelder, JC | 1 |
| Breet, NJ | 1 |
| Deneer, VH | 1 |
| Ackerstaff, RG | 2 |
| Tromp, SC | 1 |
| De Vries, JP | 2 |
| Vos, JA | 1 |
| Suttorp, MJ | 1 |
| Elsenberg, EH | 1 |
| Van Neerven, D | 1 |
| Schonewille, WJ | 1 |
| Wolters, F | 1 |
| Ten Berg, JM | 1 |
| Junghans, U | 1 |
| Siebler, M | 2 |
| Wankmüller, H | 1 |
| Leschke, M | 1 |
| Payne, DA | 1 |
| Jones, CI | 1 |
| Hayes, PD | 1 |
| Thompson, MM | 1 |
| Goodall, AH | 1 |
| Ferguson, JJ | 1 |
| Füessl, HS | 1 |
| Ouriel, K | 1 |
| Wholey, MH | 1 |
| Fayad, P | 1 |
| Katzen, BT | 1 |
| Whitlow, P | 1 |
| Frentzko, M | 1 |
| Kuntz, RE | 1 |
| Wechsler, L | 1 |
| Hopkins, N | 1 |
| Satler, L | 1 |
| Mishkel, G | 1 |
| Yadav, JS | 1 |
| Dittrich, R | 1 |
| Ritter, MA | 1 |
| Kaps, M | 1 |
| Lees, K | 1 |
| Larrue, V | 1 |
| Nabavi, DG | 1 |
| Ringelstein, EB | 1 |
| Droste, DW | 1 |
| Erdmann, E | 1 |
| Pyun, HW | 1 |
| Lee, JH | 1 |
| Choi, CG | 1 |
| Kim, SJ | 1 |
| Suh, DC | 1 |
| de Borst, GJ | 1 |
| Hilgevoord, AA | 1 |
| van der Mee, M | 1 |
| Moll, FL | 1 |
| van de Pavoordt, HD | 1 |
| Macdonald, S | 1 |
| Meinertz, T | 1 |
| Arat, A | 1 |
| Morsi, H | 1 |
| Shaltoni, H | 1 |
| Harris, JR | 1 |
| Mawad, ME | 1 |
| Lalouschek, W | 1 |
| Lang, W | 1 |
| Müllner, M | 1 |
| Goertler, M | 1 |
| Blaser, T | 1 |
| Krueger, S | 1 |
| Hofmann, K | 1 |
| Baeumer, M | 1 |
| Wallesch, CW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Antithrombotic Therapy After Left Atrial Appendage Occlusion: Double Antiplatelet Therapy vs Apixaban[NCT05632445] | Phase 4 | 160 participants (Actual) | Interventional | 2019-05-01 | Completed | ||
| PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis[NCT00153062] | Phase 4 | 20,332 participants (Actual) | Interventional | 2003-08-31 | Completed | ||
| Antiplatelet Therapy in Secondary Prevention for Patient With Silent Brain Infarction[NCT03318744] | 3,400 participants (Anticipated) | Interventional | 2018-01-31 | Not yet recruiting | |||
| Does the Magnitude of Platelet Inhibition Inversely Correlate With the Number of TCD-detected Microemboli in Asymptomatic Patients Undergoing Carotid Artery Stenting Prior to Cardiac Surgery Who Are Being Pre-treated With 300 mg or 600 mg Loading Dose of [NCT01146301] | Phase 4 | 0 participants | Interventional | 2008-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Number of patients with any of stroke, myocardial infarction, vascular death (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 1333 |
| Clopidogrel | 1333 |
Number of patients with any of stroke, myocardial infarction, vascular death, or new or worsening congestive heart failure (NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 1367 |
| Placebo | 1463 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Aspirin + Extended Release Dipyridamole | 916 |
| Clopidogrel | 898 |
(NCT00153062)
Timeframe: time since randomization; follow-up period is 1.5 to 4.4 years
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 880 |
| Placebo | 934 |
(NCT00153062)
Timeframe: Randomization to final patient contact
| Intervention | Participants (Number) |
|---|---|
| Telmisartan | 125 |
| Placebo | 151 |
2 reviews available for ticlopidine and Brain Emboli
| Article | Year |
|---|---|
Closing the loop: a 21-year audit of strategies for preventing stroke and death following carotid endarterectomy.
Topics: Angioscopy; Aspirin; Carotid Artery Diseases; Clinical Protocols; Clopidogrel; Drug Therapy, Combina | 2013 |
Platelet function testing in clinical diagnostics.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Hemorrhage; Humans; Intracranial Embolism; Intracranial T | 2011 |
9 trials available for ticlopidine and Brain Emboli
| Article | Year |
|---|---|
Dual antiplatelets reduce microembolic signals in patients with transient ischemic attack and minor stroke: subgroup analysis of CLAIR study.
Topics: Adult; Aged; Aspirin; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; I | 2014 |
The curative effect comparison of two kinds of therapeutic regimens on decreasing the relative intensity of microembolic signal in CLAIR trial.
Topics: Aspirin; Brain Ischemia; Carotid Stenosis; Cerebral Arterial Diseases; Clopidogrel; Drug Therapy, Co | 2016 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
Risk of recurrent stroke in patients with silent brain infarction in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) imaging substudy.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Benzimidazoles; Benzoates; Brain Ischemia; C | 2012 |
High versus standard clopidogrel loading in patients undergoing carotid artery stenting prior to cardiac surgery to assess the number of microemboli detected with transcranial Doppler: results of the randomized IMPACT trial.
Topics: Aged; Cardiac Surgical Procedures; Carotid Stenosis; Clopidogrel; Dose-Response Relationship, Drug; | 2013 |
Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Clopidogrel; Female; Humans; Infus | 2003 |
Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Disease Progression; Drug Therapy, Combination; Endar | 2004 |
[Prevention of atherothrombotic incidents. CHARISMA Study (The Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance].
Topics: Aged; Aspirin; Cause of Death; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Embolism | 2006 |
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyri | 2007 |
Cessation of embolic signals after antithrombotic prevention is related to reduced risk of recurrent arterioembolic transient ischaemic attack and stroke.
Topics: Aged; Aspirin; Clopidogrel; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Intracranial Emb | 2002 |
27 other studies available for ticlopidine and Brain Emboli
| Article | Year |
|---|---|
Use of Platelet Function Testing Before Pipeline Embolization Device Placement: A Multicenter Cohort Study.
Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Clopidogrel; Embolization, Therapeutic; Femal | 2017 |
Assessment of 'on-treatment platelet reactivity' and relationship with cerebral micro-embolic signals in asymptomatic and symptomatic carotid stenosis.
Topics: Aged; Aspirin; Brain; Carotid Stenosis; Case-Control Studies; Clopidogrel; Disease Progression; Fema | 2017 |
Variability in initial response to standard clopidogrel therapy, delayed conversion to clopidogrel hyper-response, and associated thromboembolic and hemorrhagic complications in patients undergoing endovascular treatment of unruptured cerebral aneurysms.
Topics: Cerebral Hemorrhage; Clopidogrel; Endovascular Procedures; Female; Humans; Intracranial Aneurysm; In | 2014 |
Association between silent embolic cerebral infarction and continuous increase of P2Y12 reaction units after neurovascular stenting.
Topics: Aspirin; Cerebral Infarction; Clopidogrel; Drug Resistance; Endovascular Procedures; Female; Humans; | 2014 |
Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy.
Topics: Aged; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Databases, Factual; Female; Fibrinolyti | 2015 |
Clopidogrel Resistance in Neurovascular Stenting: Correlations between Light Transmission Aggregometry, VerifyNow, and the Multiplate.
Topics: Aged; Brain Ischemia; Clopidogrel; Drug Resistance; Embolization, Therapeutic; Female; Humans; Intra | 2015 |
A rabbit model of cerebral microembolic signals for translational research: preclinical validation for aspirin and clopidogrel.
Topics: Animals; Aspirin; Carotid Artery Thrombosis; Chlorides; Clopidogrel; Disease Models, Animal; Drug Ev | 2016 |
[ASS plus clopidogrel in contraindication for marcumar].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combinat | 2009 |
[Platelet inhibition remains the second choice. "Anticoagulation should always be the goal" (interview by Dr. med. Jochen Aumiller)].
Topics: Aged; Anticoagulants; Aspirin; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; In | 2009 |
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinica | 2009 |
The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis.
Topics: Angiography, Digital Subtraction; Aspirin; Atorvastatin; Blood Flow Velocity; Cerebral Angiography; | 2011 |
[Abdominal tumor after persistent coughing and uncontrolled anticoagulation].
Topics: Abdomen, Acute; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coloni | 2010 |
[Intracerebral hemorrhage in anticoagulated patients: what do we do afterwards?].
Topics: Aged; Anticoagulants; Aspirin; Cerebral Hemorrhage; Clopidogrel; Female; Follow-Up Studies; Humans; | 2012 |
Insufficient platelet inhibition is related to silent embolic cerebral infarctions after coronary angiography.
Topics: Aged; Aspirin; Atherosclerosis; Basilar Artery; Carotid Arteries; Cerebral Infarction; Clopidogrel; | 2012 |
Clopidogrel load for emboli reduction in patients with symptomatic carotid stenosis undergoing urgent carotid endarterectomy.
Topics: Aged; Carotid Stenosis; Clopidogrel; Emergency Treatment; Endarterectomy, Carotid; Female; Humans; I | 2012 |
[Diagnosis and therapy of aneurysms of the atrial septum].
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Echocardiography; Echocardiography, Transesophageal; | 2003 |
If there's smoke, is there fire?
Topics: Aspirin; Clopidogrel; Drug Therapy, Combination; Endarterectomy, Carotid; Endpoint Determination; Hu | 2004 |
[Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
Topics: Arterial Occlusive Diseases; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Emboli | 2004 |
Feasibility trial of carotid stenting with and without an embolus protection device.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Blood Vessel Prosthesis Implantation; Carotid Artery, Commo | 2005 |
The use of embolic signal detection in multicenter trials to evaluate antiplatelet efficacy: signal analysis and quality control mechanisms in the CARESS (Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic carotid Stenosis) trial.
Topics: Aspirin; Carotid Stenosis; Clopidogrel; Humans; Intracranial Embolism; Multicenter Studies as Topic; | 2006 |
[More modest use in secondary prevention, risky in primary prevention].
Topics: Arteriosclerosis; Aspirin; Cause of Death; Clopidogrel; Dose-Response Relationship, Drug; Double-Bli | 2006 |
Internal carotid artery stenosis with ipsilateral persistent hypoglossal artery presenting as a multiterritorial embolic infarction: a case report.
Topics: Aged; Aspirin; Basilar Artery; Brain; Carotid Artery, Internal; Carotid Stenosis; Cerebral Infarctio | 2007 |
Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial Doppler monitoring.
Topics: Aged; Anticoagulants; Aspirin; Aspirin, Dipyridamole Drug Combination; Clopidogrel; Dextrans; Dipyri | 2007 |
[Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)].
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Aspirin; Atrial Fibrillation; Bipheny | 2007 |
Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.
Topics: Adult; Aged; Angioplasty, Balloon; Aspirin; Cerebrovascular Disorders; Clopidogrel; Drug Administrat | 2008 |
Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; | 2001 |